Next Quarterly Earnings
Thursday, May 6, 2027
Expected
Generate Biomedicines is revolutionizing drug discovery through the use of generative AI. The US-based company utilizes machine learning to program novel proteins and therapeutic agents, thereby accelerating biopharmaceutical research and the development of breakthrough therapies.
Generate Biomedicines last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.52 USD.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.